Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
MYCOPLASMA HYOPNEUMONIAE INACTIVATED , STRAIN NL1042
Elanco Animal Health, Eli Lilly and Company Limited
QI09AB13
MYCOPLASMA HYOPNEUMONIAE INACTIVATED , STRAIN NL1042
Emulsion for Injection
POM: Prescription Only Medicine as defined in relevant national legislation
Pigs
mycoplasma
Immunological - Inactivated vaccine
Authorised
2010-11-26
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Stellamune Once. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Per 2 ml dose: Active substance: Inactivated_ Mycoplasma hyopneumoniae,_ strain NL1042, between 4.5 and 5.2 log10 units*. *ELISA Relative Potency Units by comparison with a reference vaccine. Adjuvant: Amphigen Base 0.025 ml Drakeol 5 (Mineral oil) 0.075 ml. Excipients: Thiomersal 0.185 mg For a full list of exipients, see section 6.1 3 PHARMACEUTICAL FORM Emulsion for injection. Off white, translucent, semi turbid oil in water emulsion. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Fattening pigs. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For active immunisation of piglets from 3 days of age to reduce lung lesions related to infection by_ Mycoplasma_ _hyopneumoniae_ in fattening animals. Onset of immunity: 18 days following vaccination. Duration of immunity: 26 weeks following vaccination. For active immunisation of piglets from 3 weeks of age to reduce coughing and losses in weight gain related to infection by_ Mycoplasma hyopneumoniae_ in fattening animals. Onset of immunity: 3 weeks following vaccination. Duration of immunity: 23 weeks following vaccination. 4.3 CONTRAINDICATIONS None. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None. H E A L T H P R O D U C T S R E G U L A T O R Y A U T H O R I T Y ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ _D_ _a_ _t_ _e_ _ _ _P_ _r_ _i_ _n_ _t_ _e_ _d_ _ _ _2_ _7_ _/_ _0_ _3_ _/_ _2_ _0_ _1_ _5_ _C_ _R_ _N_ _ _ _7_ _0_ _1_ _8_ _1_ _7_ _2_ _p_ _a_ _g_ _e_ _ _ _n_ _u_ _m_ _b_ _e_ _r_ _:_ _ _ _1_ 4.5 SPECIAL P Read the complete document